Header cover image

Healthcare Healthcare Sector

Results

2301

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2301 companies

CVS Group

Market Cap: UK£886.7m

Engages in veterinary, pet crematoria, online pharmacy, and retail businesses.

CVSG

UK£12.60

7D

1.1%

1Y

12.7%

Dynavax Technologies

Market Cap: US$1.2b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

DVAX

US$9.50

7D

-4.0%

1Y

-17.6%

ANI Pharmaceuticals

Market Cap: US$1.2b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

ANIP

US$57.81

7D

-2.1%

1Y

-8.4%

Pediatrix Medical Group

Market Cap: US$1.2b

Provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.

MD

US$13.72

7D

-9.6%

1Y

89.0%

U.S. Physical Therapy

Market Cap: US$1.2b

Operates and manages outpatient physical therapy clinics.

USPH

US$75.42

7D

-2.4%

1Y

-24.4%

Kestra Medical Technologies

Market Cap: US$1.2b

Operates as a wearable medical device and digital healthcare company.

KMTS

US$22.86

7D

-1.0%

1Y

n/a

Neuren Pharmaceuticals

Market Cap: AU$1.8b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$14.13

7D

10.0%

1Y

-31.8%

Viridian Therapeutics

Market Cap: US$1.1b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

VRDN

US$13.50

7D

-1.2%

1Y

12.7%

Natus Medical

Market Cap: US$1.1b

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.

NTUS

US$32.96

7D

0.8%

1Y

34.4%

Ocular Therapeutix

Market Cap: US$1.1b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

OCUL

US$7.89

7D

8.1%

1Y

34.4%

Aurinia Pharmaceuticals

Market Cap: US$1.1b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.

AUPH

US$7.98

7D

-4.3%

1Y

54.7%

Establishment Labs Holdings

Market Cap: US$1.1b

A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.

ESTA

US$35.89

7D

0.04%

1Y

-30.6%

Aveanna Healthcare Holdings

Market Cap: US$1.1b

A diversified home care platform company, provides pediatric and adult healthcare services in the United States.

AVAH

US$5.30

7D

-3.5%

1Y

103.8%

BioLife Solutions

Market Cap: US$1.1b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

BLFS

US$22.35

7D

1.2%

1Y

3.5%

10x Genomics

Market Cap: US$1.1b

A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.

TXG

US$8.86

7D

6.5%

1Y

-59.9%

Spire Healthcare Group

Market Cap: UK£775.8m

Owns and operates private hospitals and clinics in the United Kingdom.

SPI

UK£1.93

7D

0%

1Y

-23.3%

OPKO Health

Market Cap: US$1.0b

A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.

OPK

US$1.30

7D

0%

1Y

-5.1%

Oculis Holding

Market Cap: US$1.0b

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.

OCS

US$19.60

7D

6.8%

1Y

64.3%

Mineralys Therapeutics

Market Cap: US$1.0b

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

MLYS

US$15.84

7D

-4.9%

1Y

28.7%

MiMedx Group

Market Cap: US$999.9m

Develops and distributes placental tissue allografts for various sectors of healthcare.

MDXG

US$6.51

7D

-5.7%

1Y

-9.0%

Phibro Animal Health

Market Cap: US$991.5m

Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.

PAHC

US$24.50

7D

5.4%

1Y

35.0%

Integra LifeSciences Holdings

Market Cap: US$986.9m

Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

IART

US$12.68

7D

0.2%

1Y

-58.8%

SS Innovations International

Market Cap: US$983.5m

Operates as a commercial-stage surgical robotics company in India and internationally.

SSII

US$5.08

7D

-43.0%

1Y

21.2%

CareDx

Market Cap: US$981.6m

Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.

CDNA

US$17.56

7D

3.0%

1Y

30.5%

CureVac

Market Cap: US$979.4m

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

CVAC

US$4.44

7D

13.8%

1Y

17.2%

Pennant Group

Market Cap: US$977.2m

Provides healthcare services in the United States.

PNTG

US$27.86

7D

-2.7%

1Y

20.1%

Harrow

Market Cap: US$966.3m

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.

HROW

US$25.92

7D

-3.0%

1Y

45.4%

Intellia Therapeutics

Market Cap: US$965.9m

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

NTLA

US$9.66

7D

5.0%

1Y

-55.4%

NeoGenomics

Market Cap: US$965.2m

Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.

NEO

US$7.42

7D

0.3%

1Y

-46.3%

Craneware

Market Cap: UK£714.4m

Develops, licenses, and supports computer software for the healthcare industry in the United States.

CRW

UK£20.70

7D

-2.1%

1Y

-13.8%

Arcus Biosciences

Market Cap: US$956.1m

A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.

RCUS

US$9.13

7D

6.0%

1Y

-39.7%

Ardelyx

Market Cap: US$949.8m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

ARDX

US$3.91

7D

-2.0%

1Y

-40.8%

Geron

Market Cap: US$949.0m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

GERN

US$1.45

7D

8.2%

1Y

-56.3%

Collegium Pharmaceutical

Market Cap: US$947.6m

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

COLL

US$28.91

7D

-1.9%

1Y

-12.9%

STAAR Surgical

Market Cap: US$936.7m

Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

STAA

US$18.08

7D

-2.0%

1Y

-55.0%

agilon health

Market Cap: US$923.1m

Provides healthcare services for seniors through primary care physicians in the communities of the United States.

AGL

US$2.35

7D

0%

1Y

-59.2%

Page 9 of 64